Search Within

Nicholas J Veomett

  1. "2013"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Adult Leukemia (6)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  3. Center for Hematologic Malignancies (6)
  4. Center for Molecular Imaging and Biotechnology (6)
  5. Department of Medicine (6)
  6. GSK Faculty (6)

More Groups

People
  1. David Scheinberg (6)
  2. Tao Dao (5)
  3. Dmitry Pankov (3)
  4. Andrew Scott (2)
  5. Ekaterina Doubrovina (2)
  6. Elliott Brea (2)

More People

Years
  1. 2013 (6)
Publications
  1. Blood (2)
  2. Expert Opinion on Biological Therapy (1)
  3. Journal of Clinical Oncology (1)
  4. Nucleic Acid Therapeutics (1)
  5. Science Translational Medicine (1)
Publishers
  1. American Society of Hematology (2)
  2. American Association for the Advancement of Science (1)
  3. American Society of Clinical Oncology (1)
  4. Mary Ann Liebert, Inc (1)
  5. Taylor & Francis Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL
    Meeting Abstract

    Dubrovsky, L.; Brea, E. J.; Veomett, N. J.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A bi-specific T cell engaging monoclonal antibody (mAb) derived from a TCR-Like mAB specific for WT1/HLA-A0201 (ESK-BiTE) shows a potent activity against human AML and Ph+ ALL in mouse models
    Meeting Abstract

    Pankov, D.; Dao, T.; Wang, Y.; Scott, A.; Korontsvit, T.; Zakhaleva, V.; Veomett, N.; Curcio, M.; Doubrovina, E.; O'Reilly, R. J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Therapeutic efficacy and cure of sensitive and T315I pan-resistant human Ph+ leukemia in mice using a TCR-like antibody to WT1/HLA-A0201 alone, or in combination with tyrosine kinase inhibitors
    Meeting Abstract

    Dubrovsky, L.; Brea, E.; Pankov, D.; Veomett, N.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Blood (2013)

    Fulltext@MSK | Save
  • Therapeutic antibodies to intracellular targets in cancer therapy
    Journal Article

    Veomett, N.; Dao, T.; Scheinberg, D. A.
    Expert Opinion on Biological Therapy (2013)

    Fulltext@MSK | Save
  • A self-assembling short oligonucleotide duplex suitable for pretargeting
    Journal Article

    Mallikaratchy, P.; Gardner, J.; Nordstrøm, L. U. R.; Veomett, N. J.; McDevitt, M. R.; Heaney, M. L.; Scheinberg, D. A.
    Nucleic Acid Therapeutics (2013)

    Fulltext@MSK | Save
  • Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
    Journal Article

    Dao, T.; Yan, S. ; Veomett, N.; Pankov, D.; Zhou, L.; Korontsvit, T.; Scott, A.; Whitten, J.; Maslak, P.; Casey, E.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save